129 related articles for article (PubMed ID: 35278898)
1. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway.
Li X; Wang X; Wang B; Chi W; Li Z; Zhang M; Shen Y; Liu X; Lu Y; Liu Y
Phytomedicine; 2022 May; 99():154027. PubMed ID: 35278898
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
3. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
4. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
5. [Dihydromyricin alleviates doxorubicin-induced myocardial injury by inhibiting NLRP3 inflammasome in rats].
Sun ZZ; Huang XX; Lin N; Lu WW; Guo HY
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1046-1051. PubMed ID: 32992421
[No Abstract] [Full Text] [Related]
6. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
7. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
8. Scutellarin Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Myocardial Fibrosis, Apoptosis and Autophagy in Rats.
Sun X; Zhou L; Han Y; Yang Q; Li X; Xin B; Chi M; Wang Y; Guo C
Chem Biodivers; 2023 Jan; 20(1):e202200450. PubMed ID: 36419360
[TBL] [Abstract][Full Text] [Related]
9. CYP2J2-derived epoxyeicosatrienoic acids protect against doxorubicin-induced cardiotoxicity by reducing oxidative stress and apoptosis via activation of the AMPK pathway.
Zhu C; Bai Y; Qiu J; Chen G; Guo X; Xu R
Heliyon; 2024 Jan; 10(1):e23526. PubMed ID: 38173517
[TBL] [Abstract][Full Text] [Related]
10. Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress.
Zhang J; Zha Y; Jiao Y; Li Y; Zhang S
Toxicology; 2023 Feb; 485():153426. PubMed ID: 36639017
[TBL] [Abstract][Full Text] [Related]
11. By restoring autophagic flux and improving mitochondrial function, corosolic acid protects against Dox-induced cardiotoxicity.
Che Y; Wang Z; Yuan Y; Zhou H; Wu H; Wang S; Tang Q
Cell Biol Toxicol; 2022 Jun; 38(3):451-467. PubMed ID: 34296331
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
13. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
Chen B; Zhang JP
Phytomedicine; 2022 Jul; 101():154130. PubMed ID: 35526324
[TBL] [Abstract][Full Text] [Related]
14. Total flavonoids of Selaginella tamariscina (P.Beauv.) Spring ameliorates doxorubicin-induced cardiotoxicity by modulating mitochondrial dysfunction and endoplasmic reticulum stress via activating MFN2/PERK.
Gao L; Yuan P; Wei Y; Fu Y; Hou Y; Li P; Chen Y; Ruan Y; Zhou N; Zheng X; Feng W
Phytomedicine; 2022 Jun; 100():154065. PubMed ID: 35358932
[TBL] [Abstract][Full Text] [Related]
15. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway.
Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799
[TBL] [Abstract][Full Text] [Related]
16. Spinacetin alleviates doxorubicin-induced cardiotoxicity by initiating protective autophagy through SIRT3/AMPK/mTOR pathways.
Liu D; Zhao L
Phytomedicine; 2022 Jul; 101():154098. PubMed ID: 35430482
[TBL] [Abstract][Full Text] [Related]
17. β-LAPachone ameliorates doxorubicin-induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice.
Nazari Soltan Ahmad S; Sanajou D; Kalantary-Charvadeh A; Hosseini V; Roshangar L; Khojastehfard M; Haiaty S; Mesgari-Abbasi M
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):364-373. PubMed ID: 31630478
[TBL] [Abstract][Full Text] [Related]
18. Liguzinediol potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis to ameliorate cardiotoxicity.
Zhu W; Lian N; Wang J; Zhao F; Liu B; Sheng J; Zhang C; Zhou X; Gao W; Xie C; Gu H; Zhang Y; Bian M; Jiang M; Li Y
Chin Med; 2024 Jun; 19(1):85. PubMed ID: 38877519
[TBL] [Abstract][Full Text] [Related]
19. Isorhapontigenin protects against doxorubicin-induced cardiotoxicity
Wang P; Wang M; Hu Y; Chen J; Cao Y; Liu C; Wu Z; Shen J; Lu J; Liu P
Acta Pharm Sin B; 2021 Mar; 11(3):680-693. PubMed ID: 33777675
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
